Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cost-effectiveness of Genetic Testing of Endocrine Tumor Patients Using a Comprehensive Hereditary Cancer Gene Panel.

The Journal of clinical endocrinology and metabolism - 18 Nov 2024

Patócs Attila, Nagy Petra, Papp János, Bozsik Anikó, Antal Bálint, Grolmusz Vince Kornél, Pócza Tímea, Butz Henriett

Abstract excerpt

INTRODUCTION: Heterogenous clinical manifestations, overlapping phenotypes, and complex genetic backgrounds are common in patients with endocrine tumors. There are no comprehensive recommendations for genetic testing and counseling of these patients compared to other hereditary cancer syndromes. The application of multigene panel testing is common in clinical genetic laboratories, but their performance for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cost-Benefit Analysis

Share to Endocrine Gland Neoplasms

Share to Genetic Testing

Share to Neoplastic Syndromes, Hereditary

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 38701358
DOI: 10.1210/clinem/dgae300
PMCID: PMC11570362

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cost-effectiveness of Genetic Testing of Endocrine Tumor Patients Using a Comprehensive Hereditary Cancer Gene Panel.PMID 38701358Read ↗

Molecular genetic testing strategies used in diagnostic flow for hereditary endocrine tumour syndromes.Semantic proximity Read ↗

Consideration for Multigene Panel Testing Outside of Cancer-Specific Genetic Testing.Semantic proximity Read ↗

Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients.Semantic proximity Read ↗

Genetic testing in inherited endocrine disorders: joint position paper of the European reference network on rare endocrine conditions (Endo-ERN).Semantic proximity Read ↗

Mutation prevalence tables for hereditary cancer derived from multigene panel testing.Semantic proximity Read ↗

Characterizing trends in clinical genetic testing: A single-center analysis of EHR data from 1.8 million patients over two decades.Semantic proximity Read ↗

Hereditary cancer testing challenges: assembling the analytical pieces to solve the patient clinical puzzle.Semantic proximity Read ↗

Changes in multi-gene cancer panels for children: A 4-year retrospective review.Semantic proximity Read ↗

Mutation prevalence tables for hereditary cancer derived from multi-gene panel testingSemantic proximity Read ↗

Economic impact of multigene panel testing for hereditary breast and ovarian cancer.Semantic proximity Read ↗

Clinical usefulness of NGS multi-gene panel testing in hereditary cancer analysisSemantic proximity Read ↗

Cancer spectrum in Mexican patients with the CHEK2 p.(Leu236Pro) variant: a retrospective study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.